Cassidy Bio

Cassidy BioCassidy Bio
Cassidy Bio

Cassidy Bio

Cassidy Bio is an AI-driven company accelerating gene editing therapeutic development with bespoke solutions for faster, smarter R&D decisions.

DR 12Speed 642023Active15
Rate

About

Cassidy Bio is an AI-powered company that designs genome editing systems, including guides and editors, by leveraging a genomic foundation model. Their specialized model turns years of trial-and-error into weeks of predictive, therapeutic-grade gene editing design, aiming to make gene editing medicines scalable, predictable, and accessible. They serve the field of gene editing therapeutic development by providing intelligence and predictive tools to accelerate the design process.
Frequently asked

What does Cassidy Bio do?

Cassidy Bio is an AI-powered company that designs genome editing systems, including guides and editors, by leveraging a genomic foundation model. Their specialized model turns years of trial-and-error into weeks of predictive, therapeutic-grade gene editing design, aiming to make gene editing medicines scalable, predictable, and accessible. They serve the field of gene editing therapeutic development by providing intelligence and predictive tools to accelerate the design process.

What is Cassidy Bio's valuation?

StartupHub estimates Cassidy Bio's effective valuation at $82.4M (range $50.0M to $120.0M, 18% confidence), based on comparable companies in the sector.

How much funding has Cassidy Bio raised?

Cassidy Bio has raised a total of $20M in funding. The most recent round on record is Seed.

When was Cassidy Bio founded?

Cassidy Bio was founded in 2023.

What industry does Cassidy Bio operate in?

Cassidy Bio operates in Workflows, Biotech, Genomics, Drug Discovery, Gene Editing, AI-Driven Protein Design.

How many employees does Cassidy Bio have?

Cassidy Bio has approximately 15 people on record.

HEADCOUNT
15
DOMAIN RATING
12
Comments

No comments yet. Be the first to share your take.